nodes	percent_of_prediction	percent_of_DWPC	metapath
Theobromine—CYP1A2—Anastrozole—breast cancer	0.183	0.275	CbGbCtD
Theobromine—CYP1A2—Toremifene—breast cancer	0.168	0.252	CbGbCtD
Theobromine—CYP2E1—Tamoxifen—breast cancer	0.106	0.159	CbGbCtD
Theobromine—CYP2E1—Mitoxantrone—breast cancer	0.103	0.155	CbGbCtD
Theobromine—CYP1A2—Tamoxifen—breast cancer	0.0613	0.0919	CbGbCtD
Theobromine—CYP1A2—Fluorouracil—breast cancer	0.0452	0.0677	CbGbCtD
Theobromine—Caffeine—ATM—breast cancer	0.00339	0.164	CrCbGaD
Theobromine—Caffeine—PIK3CB—breast cancer	0.0031	0.15	CrCbGaD
Theobromine—Caffeine—PIK3CD—breast cancer	0.0031	0.15	CrCbGaD
Theobromine—Caffeine—PIK3CA—breast cancer	0.0024	0.116	CrCbGaD
Theobromine—Dyphylline—PDE4D—breast cancer	0.00224	0.109	CrCbGaD
Theobromine—PDE4B—nipple—breast cancer	0.00184	0.0865	CbGeAlD
Theobromine—Theophylline—PDE4D—breast cancer	0.0016	0.0775	CrCbGaD
Theobromine—ADORA2A—female reproductive system—breast cancer	0.00144	0.0677	CbGeAlD
Theobromine—ADORA2A—adrenal gland—breast cancer	0.00141	0.0661	CbGeAlD
Theobromine—ADORA1—adipose tissue—breast cancer	0.00135	0.0636	CbGeAlD
Theobromine—ADORA1—female reproductive system—breast cancer	0.00124	0.0585	CbGeAlD
Theobromine—ADORA2A—endocrine gland—breast cancer	0.00122	0.0573	CbGeAlD
Theobromine—CYP1A2—nipple—breast cancer	0.00113	0.0531	CbGeAlD
Theobromine—PDE4B—endometrium—breast cancer	0.00111	0.0522	CbGeAlD
Theobromine—ADORA1—endocrine gland—breast cancer	0.00105	0.0495	CbGeAlD
Theobromine—PDE4B—pituitary gland—breast cancer	0.00101	0.0472	CbGeAlD
Theobromine—PDE4B—adipose tissue—breast cancer	0.001	0.047	CbGeAlD
Theobromine—Theophylline—CYP1B1—breast cancer	0.000995	0.0482	CrCbGaD
Theobromine—Caffeine—CYP1B1—breast cancer	0.000976	0.0473	CrCbGaD
Theobromine—PDE4B—female reproductive system—breast cancer	0.00092	0.0432	CbGeAlD
Theobromine—PDE4B—adrenal gland—breast cancer	0.000898	0.0422	CbGeAlD
Theobromine—PDE4B—bone marrow—breast cancer	0.000869	0.0408	CbGeAlD
Theobromine—PDE4B—female gonad—breast cancer	0.000838	0.0393	CbGeAlD
Theobromine—PDE4B—endocrine gland—breast cancer	0.000779	0.0366	CbGeAlD
Theobromine—ADORA1—lymph node—breast cancer	0.000728	0.0342	CbGeAlD
Theobromine—PDE4B—lymph node—breast cancer	0.000538	0.0253	CbGeAlD
Theobromine—Theophylline—CYP1A1—breast cancer	0.000537	0.026	CrCbGaD
Theobromine—Caffeine—CYP1A1—breast cancer	0.000527	0.0256	CrCbGaD
Theobromine—CYP2E1—female reproductive system—breast cancer	0.000509	0.0239	CbGeAlD
Theobromine—CYP2E1—adrenal gland—breast cancer	0.000496	0.0233	CbGeAlD
Theobromine—CYP1A2—endocrine gland—breast cancer	0.000478	0.0225	CbGeAlD
Theobromine—CYP2E1—endocrine gland—breast cancer	0.00043	0.0202	CbGeAlD
Theobromine—Theophylline—CYP2D6—breast cancer	0.0004	0.0194	CrCbGaD
Theobromine—Caffeine—CYP2D6—breast cancer	0.000392	0.019	CrCbGaD
Theobromine—Theophylline—CYP3A4—breast cancer	0.000343	0.0166	CrCbGaD
Theobromine—Caffeine—CYP3A4—breast cancer	0.000337	0.0163	CrCbGaD
Theobromine—Caffeine—ABCB1—breast cancer	0.00028	0.0136	CrCbGaD
Theobromine—CYP1A2—Metabolism—HPSE—breast cancer	3.25e-05	0.000112	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—BRIP1—breast cancer	3.25e-05	0.000112	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—LDHB—breast cancer	3.25e-05	0.000112	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—KRAS—breast cancer	3.23e-05	0.000111	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—PIK3CA—breast cancer	3.22e-05	0.000111	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—SERPINE1—breast cancer	3.22e-05	0.000111	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—LEP—breast cancer	3.21e-05	0.00011	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYP17A1—breast cancer	3.2e-05	0.00011	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—KRAS—breast cancer	3.19e-05	0.000109	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CAV1—breast cancer	3.18e-05	0.000109	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ENO1—breast cancer	3.17e-05	0.000109	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PTGS1—breast cancer	3.17e-05	0.000109	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—KDR—breast cancer	3.14e-05	0.000108	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—NOS3—breast cancer	3.11e-05	0.000107	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYP2D6—breast cancer	3.1e-05	0.000107	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTA3—breast cancer	3.08e-05	0.000106	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—HMMR—breast cancer	3.08e-05	0.000106	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ABCC1—breast cancer	3.08e-05	0.000106	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—NOS3—breast cancer	3.07e-05	0.000106	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ESR1—breast cancer	3.06e-05	0.000105	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NCOA2—breast cancer	3.05e-05	0.000105	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—FN1—breast cancer	3.02e-05	0.000104	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—NFKBIA—breast cancer	2.99e-05	0.000103	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PPARGC1B—breast cancer	2.98e-05	0.000102	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—PIK3CA—breast cancer	2.96e-05	0.000102	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—NOTCH1—breast cancer	2.96e-05	0.000102	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—FASN—breast cancer	2.96e-05	0.000102	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MDM2—breast cancer	2.95e-05	0.000101	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—BCHE—breast cancer	2.94e-05	0.000101	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—RAF1—breast cancer	2.94e-05	0.000101	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—RELA—breast cancer	2.93e-05	0.000101	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—PIK3CA—breast cancer	2.93e-05	0.000101	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MDM2—breast cancer	2.92e-05	0.0001	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—ERBB2—breast cancer	2.91e-05	0.0001	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—SLC5A5—breast cancer	2.91e-05	9.99e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—RAF1—breast cancer	2.91e-05	9.98e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.9e-05	9.98e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.9e-05	9.98e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—RELA—breast cancer	2.89e-05	9.94e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CG—breast cancer	2.89e-05	9.94e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—APC—breast cancer	2.89e-05	9.94e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—KIT—breast cancer	2.89e-05	9.94e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—ERBB2—breast cancer	2.88e-05	9.88e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PIK3CB—breast cancer	2.87e-05	9.87e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MTOR—breast cancer	2.87e-05	9.87e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—EGF—breast cancer	2.86e-05	9.83e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MTOR—breast cancer	2.84e-05	9.75e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PIK3CB—breast cancer	2.84e-05	9.75e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTA4—breast cancer	2.82e-05	9.68e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CA9—breast cancer	2.82e-05	9.68e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NQO1—breast cancer	2.81e-05	9.64e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—SLC2A1—breast cancer	2.81e-05	9.64e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.78e-05	9.55e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—MAPK3—breast cancer	2.77e-05	9.52e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CXCL8—breast cancer	2.76e-05	9.48e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.75e-05	9.46e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GPX2—breast cancer	2.75e-05	9.43e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTA2—breast cancer	2.75e-05	9.43e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—HRAS—breast cancer	2.74e-05	9.42e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYP3A4—breast cancer	2.74e-05	9.4e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CXCL8—breast cancer	2.73e-05	9.37e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—BRAF—breast cancer	2.72e-05	9.34e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—SULT1A1—breast cancer	2.71e-05	9.32e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GPX4—breast cancer	2.71e-05	9.32e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—HRAS—breast cancer	2.71e-05	9.31e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CDKN1B—breast cancer	2.7e-05	9.26e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYP1B1—breast cancer	2.69e-05	9.25e-05	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—AKT1—breast cancer	2.67e-05	9.16e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CDKN1B—breast cancer	2.66e-05	9.15e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IGF1—breast cancer	2.65e-05	9.1e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—IDH1—breast cancer	2.65e-05	9.1e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTA1—breast cancer	2.65e-05	9.1e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—AKT2—breast cancer	2.65e-05	9.09e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CASP3—breast cancer	2.64e-05	9.07e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—HSP90AA1—breast cancer	2.64e-05	9.07e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL2—breast cancer	2.64e-05	9.06e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—EGFR—breast cancer	2.64e-05	9.06e-05	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—AKT1—breast cancer	2.63e-05	9.05e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—IL6—breast cancer	2.62e-05	9.01e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NAT2—breast cancer	2.62e-05	9e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CASP3—breast cancer	2.61e-05	8.97e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL2—breast cancer	2.61e-05	8.95e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—IL6—breast cancer	2.59e-05	8.91e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCND1—breast cancer	2.57e-05	8.83e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NCOA1—breast cancer	2.57e-05	8.82e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—JUN—breast cancer	2.57e-05	8.81e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CTNNB1—breast cancer	2.55e-05	8.75e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CD—breast cancer	2.54e-05	8.74e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCND1—breast cancer	2.54e-05	8.73e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—JUN—breast cancer	2.54e-05	8.71e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—STK11—breast cancer	2.53e-05	8.69e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYP19A1—breast cancer	2.53e-05	8.69e-05	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—PIK3CA—breast cancer	2.52e-05	8.66e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—SERPINE1—breast cancer	2.52e-05	8.64e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CTNNB1—breast cancer	2.52e-05	8.64e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MMP9—breast cancer	2.5e-05	8.57e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—KRAS—breast cancer	2.49e-05	8.56e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CDKN1A—breast cancer	2.49e-05	8.54e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PTEN—breast cancer	2.48e-05	8.52e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MMP9—breast cancer	2.47e-05	8.47e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CDKN1A—breast cancer	2.46e-05	8.44e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PTEN—breast cancer	2.45e-05	8.42e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MAPK8—breast cancer	2.43e-05	8.34e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—AKT1—breast cancer	2.42e-05	8.32e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—NOS3—breast cancer	2.4e-05	8.25e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MAPK8—breast cancer	2.4e-05	8.24e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—AKT1—breast cancer	2.39e-05	8.22e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.37e-05	8.13e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—COMT—breast cancer	2.35e-05	8.08e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTP1—breast cancer	2.34e-05	8.04e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—HMOX1—breast cancer	2.31e-05	7.93e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ITPR1—breast cancer	2.3e-05	7.91e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—SRC—breast cancer	2.3e-05	7.91e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MED12—breast cancer	2.3e-05	7.89e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—DPYD—breast cancer	2.3e-05	7.89e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—PIK3CA—breast cancer	2.29e-05	7.86e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MDM2—breast cancer	2.28e-05	7.83e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—SRC—breast cancer	2.27e-05	7.81e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—RAF1—breast cancer	2.27e-05	7.8e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—RELA—breast cancer	2.26e-05	7.77e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ALDOA—breast cancer	2.26e-05	7.77e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ERBB2—breast cancer	2.25e-05	7.72e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—VEGFA—breast cancer	2.24e-05	7.7e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—STAT3—breast cancer	2.22e-05	7.62e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MTOR—breast cancer	2.22e-05	7.62e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CB—breast cancer	2.22e-05	7.62e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ABCB1—breast cancer	2.22e-05	7.61e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—VEGFA—breast cancer	2.21e-05	7.61e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NCOA3—breast cancer	2.19e-05	7.54e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—STAT3—breast cancer	2.19e-05	7.53e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—SLC2A2—breast cancer	2.18e-05	7.49e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—TYMS—breast cancer	2.18e-05	7.48e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.16e-05	7.41e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NCOR1—breast cancer	2.15e-05	7.39e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTM1—breast cancer	2.15e-05	7.39e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PLA2G4A—breast cancer	2.15e-05	7.39e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CPT1A—breast cancer	2.14e-05	7.33e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MTR—breast cancer	2.14e-05	7.33e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ABCG2—breast cancer	2.14e-05	7.33e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CXCL8—breast cancer	2.13e-05	7.32e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MAPK3—breast cancer	2.12e-05	7.28e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—HRAS—breast cancer	2.12e-05	7.27e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MAPK3—breast cancer	2.1e-05	7.2e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—HPGDS—breast cancer	2.09e-05	7.19e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CDKN1B—breast cancer	2.08e-05	7.15e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—HBA1—breast cancer	2.08e-05	7.15e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MYC—breast cancer	2.06e-05	7.08e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GPX1—breast cancer	2.06e-05	7.08e-05	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—AKT1—breast cancer	2.06e-05	7.07e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TGFB1—breast cancer	2.06e-05	7.07e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYP1A1—breast cancer	2.04e-05	7.01e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CASP3—breast cancer	2.04e-05	7.01e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MYC—breast cancer	2.04e-05	7e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL2—breast cancer	2.04e-05	7e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TGFB1—breast cancer	2.03e-05	6.98e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ACHE—breast cancer	2.03e-05	6.98e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTT1—breast cancer	2.03e-05	6.98e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—IL6—breast cancer	2.03e-05	6.96e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ERCC2—breast cancer	2.02e-05	6.95e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—EGFR—breast cancer	2.02e-05	6.93e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—EGFR—breast cancer	1.99e-05	6.85e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCND1—breast cancer	1.99e-05	6.82e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—JUN—breast cancer	1.98e-05	6.8e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CTNNB1—breast cancer	1.97e-05	6.75e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MMP9—breast cancer	1.93e-05	6.62e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYP17A1—breast cancer	1.92e-05	6.6e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CDKN1A—breast cancer	1.92e-05	6.6e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PTEN—breast cancer	1.92e-05	6.58e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—KRAS—breast cancer	1.91e-05	6.55e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ENO1—breast cancer	1.9e-05	6.54e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PTGS1—breast cancer	1.9e-05	6.54e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—MTHFR—breast cancer	1.9e-05	6.53e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.9e-05	6.51e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—KRAS—breast cancer	1.88e-05	6.47e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MAPK8—breast cancer	1.87e-05	6.44e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.87e-05	6.43e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—AKT1—breast cancer	1.87e-05	6.42e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYP2D6—breast cancer	1.87e-05	6.41e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NCOA2—breast cancer	1.83e-05	6.29e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—SRC—breast cancer	1.78e-05	6.1e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—FASN—breast cancer	1.78e-05	6.1e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—BCHE—breast cancer	1.77e-05	6.08e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CAV1—breast cancer	1.75e-05	6.03e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PIK3CA—breast cancer	1.75e-05	6.01e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—SLC5A5—breast cancer	1.75e-05	6e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—VEGFA—breast cancer	1.73e-05	5.94e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PIK3CA—breast cancer	1.73e-05	5.94e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—STAT3—breast cancer	1.71e-05	5.89e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TP53—breast cancer	1.69e-05	5.82e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—SLC2A1—breast cancer	1.69e-05	5.8e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NQO1—breast cancer	1.69e-05	5.8e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TP53—breast cancer	1.67e-05	5.75e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.65e-05	5.68e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYP3A4—breast cancer	1.65e-05	5.65e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.64e-05	5.62e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MAPK3—breast cancer	1.64e-05	5.62e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HRAS—breast cancer	1.62e-05	5.56e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYP1B1—breast cancer	1.62e-05	5.56e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HRAS—breast cancer	1.6e-05	5.5e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CG—breast cancer	1.6e-05	5.49e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MYC—breast cancer	1.59e-05	5.47e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TGFB1—breast cancer	1.59e-05	5.46e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.59e-05	5.45e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—EGFR—breast cancer	1.56e-05	5.35e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL6—breast cancer	1.55e-05	5.33e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NCOA1—breast cancer	1.54e-05	5.3e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL6—breast cancer	1.53e-05	5.26e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYP19A1—breast cancer	1.52e-05	5.23e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—STK11—breast cancer	1.52e-05	5.23e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—KRAS—breast cancer	1.47e-05	5.05e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—AKT1—breast cancer	1.43e-05	4.91e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.43e-05	4.91e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—COMT—breast cancer	1.41e-05	4.86e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—AKT1—breast cancer	1.41e-05	4.85e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTP1—breast cancer	1.41e-05	4.84e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CD—breast cancer	1.4e-05	4.82e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—HMOX1—breast cancer	1.39e-05	4.77e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ALB—breast cancer	1.39e-05	4.76e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ITPR1—breast cancer	1.39e-05	4.76e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CA—breast cancer	1.35e-05	4.64e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ABCB1—breast cancer	1.33e-05	4.58e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NOS3—breast cancer	1.33e-05	4.56e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—TYMS—breast cancer	1.31e-05	4.5e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TP53—breast cancer	1.31e-05	4.49e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NCOR1—breast cancer	1.29e-05	4.44e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.29e-05	4.44e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTM1—breast cancer	1.29e-05	4.44e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HRAS—breast cancer	1.25e-05	4.3e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GPX1—breast cancer	1.24e-05	4.26e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYP1A1—breast cancer	1.23e-05	4.21e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CB—breast cancer	1.22e-05	4.21e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ERCC2—breast cancer	1.22e-05	4.18e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PTGS2—breast cancer	1.21e-05	4.17e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL6—breast cancer	1.2e-05	4.11e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MTHFR—breast cancer	1.14e-05	3.93e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—AKT1—breast cancer	1.1e-05	3.79e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PTEN—breast cancer	1.06e-05	3.63e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CAV1—breast cancer	1.05e-05	3.62e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.01e-05	3.46e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CG—breast cancer	9.61e-06	3.3e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CD—breast cancer	8.44e-06	2.9e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ALB—breast cancer	8.34e-06	2.86e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NOS3—breast cancer	7.97e-06	2.74e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CA—breast cancer	7.46e-06	2.56e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CB—breast cancer	7.36e-06	2.53e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PTGS2—breast cancer	7.29e-06	2.51e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PTEN—breast cancer	6.36e-06	2.18e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—AKT1—breast cancer	6.1e-06	2.09e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CA—breast cancer	4.49e-06	1.54e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—AKT1—breast cancer	3.67e-06	1.26e-05	CbGpPWpGaD
